Harmony Biosciences Holdings, Inc. HRMY Debt Repayments
Debt Repayments at other companies
Other financials
Where this comes from
Reported directly by Harmony Biosciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RepaymentsOfLongTermDebt.
The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Harmony Biosciences Holdings, Inc.'s debt repayments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Harmony Biosciences Holdings, Inc.'s debt repayments?
- Harmony Biosciences Holdings, Inc. (HRMY) reported debt repayments of $5M in Q1 2026.
- How has Harmony Biosciences Holdings, Inc.'s debt repayments changed year-over-year?
- Harmony Biosciences Holdings, Inc.'s debt repayments increased by 33.3% year-over-year, from $3.75M to $5M.
- What is the long-term trend for Harmony Biosciences Holdings, Inc.'s debt repayments?
- Over 4 years (2021 to 2025), Harmony Biosciences Holdings, Inc.'s debt repayments has grown at a 138.8% compound annual growth rate (CAGR), from $500K to $16.25M.
- What does debt repayments mean?
- Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.